ArticleFrontiers in molecular biosciences2020

Efficacy and Safety of TACE Combined With Sorafenib Plus Immune Checkpoint Inhibitors for the Treatment of Intermediate and Advanced TACE-Refractory Hepatocellular Carcinoma: A Retrospective Study.

Liyun Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.